四环医药入选2023中国医药创新企业100强榜单「第一梯级企业」 Sihuan Pharmaceutical Holdings Group Ltd. Oct 13, 2023 18:09 HKT/SGT Read More
四環醫藥入選2023中國醫藥創新企業100強榜單「第一梯級企業」 Sihuan Pharmaceutical Holdings Group Ltd. Oct 13, 2023 18:08 HKT/SGT Read More
Sihuan Pharmaceutical Was Selected As One Of The First Echelon Of Enterprises In The list of China's Top 100 Pharmaceutical Innovative Enterprises in 2023 Sihuan Pharmaceutical Holdings Group Ltd. Oct 13, 2023 18:07 HKT/SGT Read More
Cardiol Therapeutics Announces Advancements in Therapies for Inflammatory Heart Diseases Cardiol Therapeutics Oct 13, 2023 09:12 HKT/SGT Read More
Eisai to Present Research from Oncology Portfolio and Pipeline at ESMO Congress 2023 Eisai Oct 11, 2023 12:07 HKT/SGT Read More
Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins Fujitsu Ltd Oct 10, 2023 15:29 HKT/SGT Read More
ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory AcroMeta Group Limited Oct 06, 2023 17:30 HKT/SGT Read More
Eisai: Notice of Absorption-Type Merger (Simplified Merger/Short-Form Merger) of KAN Research Institute, Inc. Eisai Oct 04, 2023 18:08 HKT/SGT Read More
ZeptoMetrix Awarded in Vitro Diagnostic Regulation (IVDR) Certification ZeptoMetrix Oct 03, 2023 21:00 HKT/SGT Read More
HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101 HanchorBio Inc Oct 03, 2023 19:30 HKT/SGT Read More
绿竹生物核心产品重组带状疱疹疫苗LZ901于中国启动III期临床试验 Beijing Luzhu Biotechnology Co., Ltd. Sep 29, 2023 10:31 HKT/SGT Read More
綠竹生物核心產品重組帶狀皰疹疫苗LZ901於中國啟動III期臨床試驗 Beijing Luzhu Biotechnology Co., Ltd. Sep 29, 2023 10:30 HKT/SGT Read More
Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance" Eisai Sep 28, 2023 13:49 HKT/SGT Read More
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs Hyris Sep 27, 2023 17:00 HKT/SGT Read More
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan Eisai Sep 25, 2023 14:17 HKT/SGT Read More
致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌 Wuhan YZY Biopharma Co., Ltd. Sep 25, 2023 12:47 HKT/SGT Read More
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌 Wuhan YZY Biopharma Co., Ltd. Sep 25, 2023 12:46 HKT/SGT Read More
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK Wuhan YZY Biopharma Co., Ltd. Sep 25, 2023 12:45 HKT/SGT Read More